Merav Weinryb

Venture Capital, Corporate Venture Capital · Israel

Merav Weinryb is a venture capital investor and corporate venture capital investor based in Israel. They invest in Health Care, Wearables, Autonomous Vehicles and E-commerce. Their portfolio includes Shadowfax, MoveInSync, Dunamu and Bell.ai and 76 other companies.

Industries

Portfolio companies (80)

And 20 more in the full profile.

Similar investors in Health Care

  • Renana Ashkenazi

    Venture Capital, Private Equity Firm, Investor · Israel

    SeedHealth CareDeepTechEnterprise SoftwareApps

    Portfolio: NeuroBlade, CommonGround-AI

    Contact details available

  • Nir Falevich

    Venture Capital, Micro VC · Israel

    Health CareE-commercePaymentsWomen Founded

    Portfolio: PayBox, Railsbank

    Contact details available

  • Aaron MankovskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · Israel

    Early Stage VentureSeries ANon Equity AssistanceHealth CareCybersecurityEnterprise SoftwareRobotics

    Portfolio: Silk, Tabit

    Contact details available

  • Shlomi Zadok

    Angel/Individual · Israel

    Health CareEnterprise SoftwareMobileClean Technology

    Contact details available

  • Rami Kalish

    Venture Capital, Entrepreneurship Program, Private Equity Firm · Israel

    Early Stage VentureSeries ANon Equity AssistanceHealth CareCybersecurityEnterprise SoftwareRobotics

    Portfolio: Avantis Team, Red Bend Software

    Contact details available

  • Pini Orbach

    Venture Capital, Private Equity Firm · Israel

    Health CareHospitalsSportsEnterprise Software

    Portfolio: Quiet Therapeutics, Percepto

    Contact details available

  • Haim SadgerVerified

    Venture Capital · Israel

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Taykey, Vibrant

    Contact details available

  • Naama Ben Dov

    Venture Capital · Israel

    Health CareAutonomous VehiclesCybersecurityComputer Vision

    Portfolio: Medigate, AcceloWeb

    Contact details available